nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.123	0.28	CbGbCtD
Dolasetron—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.077	0.175	CbGbCtD
Dolasetron—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0716	0.163	CbGbCtD
Dolasetron—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0528	0.12	CbGbCtD
Dolasetron—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0329	0.0747	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0323	0.0734	CbGbCtD
Dolasetron—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0301	0.0684	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0206	0.0467	CbGbCtD
Dolasetron—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.0155	0.335	CbGeAlD
Dolasetron—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.0118	0.255	CbGeAlD
Dolasetron—HTR3A—nerve—peripheral nervous system neoplasm	0.00604	0.131	CbGeAlD
Dolasetron—HTR3A—ganglion—peripheral nervous system neoplasm	0.00596	0.129	CbGeAlD
Dolasetron—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00293	0.0634	CbGeAlD
Dolasetron—HTR3A—brainstem—peripheral nervous system neoplasm	0.00259	0.0561	CbGeAlD
Dolasetron—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000952	0.0206	CbGeAlD
Dolasetron—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000531	0.00103	CcSEcCtD
Dolasetron—Malaise—Etoposide—peripheral nervous system neoplasm	0.000529	0.00103	CcSEcCtD
Dolasetron—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000529	0.00103	CcSEcCtD
Dolasetron—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000527	0.00103	CcSEcCtD
Dolasetron—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000527	0.00103	CcSEcCtD
Dolasetron—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00102	CcSEcCtD
Dolasetron—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00102	CcSEcCtD
Dolasetron—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.00102	CcSEcCtD
Dolasetron—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000523	0.00102	CcSEcCtD
Dolasetron—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000523	0.00102	CcSEcCtD
Dolasetron—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00102	CcSEcCtD
Dolasetron—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00102	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.00102	CcSEcCtD
Dolasetron—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000519	0.00101	CcSEcCtD
Dolasetron—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000515	0.001	CcSEcCtD
Dolasetron—Rash—Topotecan—peripheral nervous system neoplasm	0.000514	0.001	CcSEcCtD
Dolasetron—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000514	0.001	CcSEcCtD
Dolasetron—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000514	0.001	CcSEcCtD
Dolasetron—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000513	0.001	CcSEcCtD
Dolasetron—Cough—Etoposide—peripheral nervous system neoplasm	0.000512	0.000997	CcSEcCtD
Dolasetron—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000512	0.000996	CcSEcCtD
Dolasetron—Headache—Topotecan—peripheral nervous system neoplasm	0.000511	0.000995	CcSEcCtD
Dolasetron—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00051	0.000994	CcSEcCtD
Dolasetron—Rash—Tretinoin—peripheral nervous system neoplasm	0.00051	0.000994	CcSEcCtD
Dolasetron—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00051	0.000993	CcSEcCtD
Dolasetron—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00051	0.000993	CcSEcCtD
Dolasetron—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00051	0.000993	CcSEcCtD
Dolasetron—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000509	0.000992	CcSEcCtD
Dolasetron—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000508	0.00099	CcSEcCtD
Dolasetron—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000989	CcSEcCtD
Dolasetron—Headache—Tretinoin—peripheral nervous system neoplasm	0.000507	0.000987	CcSEcCtD
Dolasetron—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000507	0.000987	CcSEcCtD
Dolasetron—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000506	0.000986	CcSEcCtD
Dolasetron—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.000984	CcSEcCtD
Dolasetron—Pain—Vincristine—peripheral nervous system neoplasm	0.000505	0.000984	CcSEcCtD
Dolasetron—Constipation—Vincristine—peripheral nervous system neoplasm	0.000505	0.000984	CcSEcCtD
Dolasetron—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000505	0.000984	CcSEcCtD
Dolasetron—Rash—Melphalan—peripheral nervous system neoplasm	0.000504	0.000981	CcSEcCtD
Dolasetron—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000503	0.00098	CcSEcCtD
Dolasetron—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.000977	CcSEcCtD
Dolasetron—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000499	0.000973	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000971	CcSEcCtD
Dolasetron—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000498	0.00097	CcSEcCtD
Dolasetron—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000493	0.000961	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000957	CcSEcCtD
Dolasetron—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000488	0.000951	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.00095	CcSEcCtD
Dolasetron—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000487	0.000949	CcSEcCtD
Dolasetron—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000487	0.000949	CcSEcCtD
Dolasetron—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.000944	CcSEcCtD
Dolasetron—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.000944	CcSEcCtD
Dolasetron—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000483	0.000941	CcSEcCtD
Dolasetron—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000483	0.00094	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000938	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000936	CcSEcCtD
Dolasetron—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000479	0.000932	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000476	0.000927	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000925	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000925	CcSEcCtD
Dolasetron—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000474	0.000924	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000915	CcSEcCtD
Dolasetron—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.00047	0.0102	CbGeAlD
Dolasetron—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000469	0.000914	CcSEcCtD
Dolasetron—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000469	0.000913	CcSEcCtD
Dolasetron—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000467	0.00091	CcSEcCtD
Dolasetron—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000467	0.00091	CcSEcCtD
Dolasetron—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000467	0.00091	CcSEcCtD
Dolasetron—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000466	0.000907	CcSEcCtD
Dolasetron—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000463	0.000901	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000901	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000899	CcSEcCtD
Dolasetron—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000456	0.000889	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000886	CcSEcCtD
Dolasetron—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000454	0.000885	CcSEcCtD
Dolasetron—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000452	0.000881	CcSEcCtD
Dolasetron—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000452	0.00088	CcSEcCtD
Dolasetron—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000447	0.000871	CcSEcCtD
Dolasetron—Pain—Cisplatin—peripheral nervous system neoplasm	0.000447	0.00087	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000868	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000859	CcSEcCtD
Dolasetron—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00044	0.000857	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000856	CcSEcCtD
Dolasetron—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000435	0.000848	CcSEcCtD
Dolasetron—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000434	0.000845	CcSEcCtD
Dolasetron—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000431	0.000839	CcSEcCtD
Dolasetron—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00043	0.000837	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000834	CcSEcCtD
Dolasetron—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000427	0.000831	CcSEcCtD
Dolasetron—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000425	0.000829	CcSEcCtD
Dolasetron—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000424	0.000826	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000824	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000819	CcSEcCtD
Dolasetron—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00042	0.000817	CcSEcCtD
Dolasetron—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000417	0.000812	CcSEcCtD
Dolasetron—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000416	0.00081	CcSEcCtD
Dolasetron—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000413	0.000804	CcSEcCtD
Dolasetron—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000413	0.000804	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000799	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000799	CcSEcCtD
Dolasetron—Pain—Etoposide—peripheral nervous system neoplasm	0.000409	0.000797	CcSEcCtD
Dolasetron—Constipation—Etoposide—peripheral nervous system neoplasm	0.000409	0.000797	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000795	CcSEcCtD
Dolasetron—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00079	CcSEcCtD
Dolasetron—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000404	0.000787	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000781	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000773	CcSEcCtD
Dolasetron—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000394	0.000768	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000763	CcSEcCtD
Dolasetron—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000391	0.000762	CcSEcCtD
Dolasetron—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000391	0.000761	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000758	CcSEcCtD
Dolasetron—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.000753	CcSEcCtD
Dolasetron—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000386	0.000752	CcSEcCtD
Dolasetron—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000385	0.00075	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000749	CcSEcCtD
Dolasetron—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.000748	CcSEcCtD
Dolasetron—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00038	0.000741	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000739	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000739	CcSEcCtD
Dolasetron—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000378	0.000737	CcSEcCtD
Dolasetron—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000378	0.000737	CcSEcCtD
Dolasetron—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000375	0.00073	CcSEcCtD
Dolasetron—Rash—Vincristine—peripheral nervous system neoplasm	0.000373	0.000726	CcSEcCtD
Dolasetron—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000372	0.000725	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000725	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000723	CcSEcCtD
Dolasetron—Headache—Vincristine—peripheral nervous system neoplasm	0.00037	0.000721	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000715	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000709	CcSEcCtD
Dolasetron—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000357	0.000696	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000693	CcSEcCtD
Dolasetron—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000353	0.000687	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000686	CcSEcCtD
Dolasetron—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000683	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.00067	CcSEcCtD
Dolasetron—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000343	0.000669	CcSEcCtD
Dolasetron—Chills—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00066	CcSEcCtD
Dolasetron—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000339	0.00066	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000657	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000656	CcSEcCtD
Dolasetron—Rash—Cisplatin—peripheral nervous system neoplasm	0.000329	0.000642	CcSEcCtD
Dolasetron—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000329	0.000641	CcSEcCtD
Dolasetron—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000327	0.000638	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000635	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000632	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000631	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000627	CcSEcCtD
Dolasetron—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000316	0.000617	CcSEcCtD
Dolasetron—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000611	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000608	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000594	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000592	CcSEcCtD
Dolasetron—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000588	CcSEcCtD
Dolasetron—Rash—Etoposide—peripheral nervous system neoplasm	0.000302	0.000588	CcSEcCtD
Dolasetron—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000301	0.000587	CcSEcCtD
Dolasetron—Headache—Etoposide—peripheral nervous system neoplasm	0.0003	0.000584	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000584	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00058	CcSEcCtD
Dolasetron—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000577	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000575	CcSEcCtD
Dolasetron—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000574	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000566	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000563	CcSEcCtD
Dolasetron—Cough—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000559	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000555	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000553	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00055	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000548	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000545	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000545	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000545	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000544	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000543	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000539	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000534	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000533	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000532	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000531	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000527	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000524	CcSEcCtD
Dolasetron—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000523	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000523	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000521	CcSEcCtD
Dolasetron—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000517	CcSEcCtD
Dolasetron—Shock—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000514	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000513	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000512	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000512	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00051	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000505	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000504	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000504	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000504	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000503	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000498	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000498	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000493	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000488	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000488	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000484	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000484	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000476	CcSEcCtD
Dolasetron—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000476	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000473	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000472	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000469	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000467	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000466	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000465	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000461	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00046	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000454	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000452	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000451	CcSEcCtD
Dolasetron—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000447	CcSEcCtD
Dolasetron—Pain—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000447	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000441	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000434	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000431	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000431	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00043	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000427	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000426	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00042	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000417	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000415	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000414	CcSEcCtD
Dolasetron—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000414	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000413	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000413	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000398	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000395	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000385	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000384	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000382	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000382	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000375	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00037	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000358	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000356	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000347	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000346	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000342	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000331	CcSEcCtD
Dolasetron—Rash—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00033	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000329	CcSEcCtD
Dolasetron—Headache—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000327	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00032	CcSEcCtD
Dolasetron—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000305	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000305	CcSEcCtD
Dolasetron—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000303	CcSEcCtD
